2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide

C35H59NO3S — CID 177071308

IUPAC2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide
SMILESCC(=O)CCOCCNC(=O)CSC1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1
InChIInChI=1S/C35H59NO3S/c1-24(2)8-7-9-25(3)30-12-13-31-29-11-10-27-22-28(14-17-34(27,5)32(29)15-18-35(30,31)6)40-23-33(38)36-19-21-39-20-16-26(4)37/h10,24-25,28-32H,7-9,11-23H2,1-6H3,(H,36,38)/t25-,28?,29+,30-,31+,32+,34+,35-/m1/s1
InChIKeySKKJPUUIVRVQDE-AGQNPBTHSA-N
MW573.93 g/mol
LogP8.24
Rot. Bonds14

About 2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide

2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide (PubChem CID 177071308) has the molecular formula C35H59NO3S and a molecular weight of 573.93 g/mol. Its IUPAC name is 2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide.

Molecular Properties

Compound Name2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide
PubChem CID177071308
Molecular FormulaC35H59NO3S
Molecular Weight573.93 g/mol
Exact Mass573.42
IUPAC Name2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide
SMILESCC(=O)CCOCCNC(=O)CSC1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1
InChIInChI=1S/C35H59NO3S/c1-24(2)8-7-9-25(3)30-12-13-31-29-11-10-27-22-28(14-17-34(27,5)32(29)15-18-35(30,31)6)40-23-33(38)36-19-21-39-20-16-26(4)37/h10,24-25,28-32H,7-9,11-23H2,1-6H3,(H,36,38)/t25-,28?,29+,30-,31+,32+,34+,35-/m1/s1
InChIKeySKKJPUUIVRVQDE-AGQNPBTHSA-N
XLogP8.24
TPSA55.40 Ų
H-Bond Donors1
H-Bond Acceptors4
Rotatable Bonds14
Heavy Atoms40
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500573.93
LogP ≤ 58.24
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 104

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'isolated_alkene', 'substructure': 'N/A'}

Analyze 2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide?
The IUPAC name of 2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide (CID 177071308) is 2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide.
What is the SMILES notation for 2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide?
The canonical SMILES for 2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide is CC(=O)CCOCCNC(=O)CSC1CC[C@@]2(C)C(=CC[C@H]3[C@@H]4CC[C@H]([C@H](C)CCCC(C)C)[C@@]4(C)CC[C@@H]32)C1.
What is the InChIKey of 2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide?
The InChIKey is SKKJPUUIVRVQDE-AGQNPBTHSA-N. The full InChI is InChI=1S/C35H59NO3S/c1-24(2)8-7-9-25(3)30-12-13-31-29-11-10-27-22-28(14-17-34(27,5)32(29)15-18-35(30,31)6)40-23-33(38)36-19-21-39-20-16-26(4)37/h10,24-25,28-32H,7-9,11-23H2,1-6H3,(H,36,38)/t25-,28?,29+,30-,31+,32+,34+,35-/m1/s1.
What are the key properties of 2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide?
2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide has a molecular weight of 573.93 g/mol, XLogP of 8.24, 14 rotatable bonds, 1 hydrogen bond donors, and 4 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[[(8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl]sulfanyl]-N-[2-(3-oxobutoxy)ethyl]acetamide is sourced from PubChem (CID 177071308), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).